Top News
Next Story

Siddharth Mittal takes charge as CEO & Joint Managing Director of Biocon IFC to Anchor $200 Million Investment in Mahindra Finance After positive sales in October, Maruti Suzuki sales drops 2% in… Mahindra's November sales dips by 9%, Farm equipment sales slips… Airtel, Vodafone-Idea to hike tariff from 3rd December

Send Push
03rd December, 2019 13:39 IST

Biznextindia: Siddharth Mittal has taken over as Chief Executive Officer & Joint Managing Director of the biopharmaceuticals company Biocon Ltd starting December 1, 2019. Mr. Mittal has been serving as Biocon’s Chief Financial Officer (CFO) since August 2014.

Mr. Mittal takes over from Dr Arun Chandavarkar who retired as Chief Executive Officer & Joint Managing Director of Biocon on Nov 30, 2019, after 29 years of outstanding contribution to the evolution and success of Biocon.

Mr. Mittal has been a core member of the leadership team at Biocon since May 2013 and has played an instrumental role in the biosimilars success story so far including the restructuring of the biosimilars business into Biocon Biologics with an objective to unlock value for Biocon’s shareholders. He also played a pivotal role in managing global collaborations. As the CFO, he has successfully created a compelling Shareholder Value Proposition for Biocon over the last 6 years, including value unlocking of Syngene which was listed on the Indian capital markets in 2015.

Explore more on Newspoint
Loving Newspoint? Download the app now